Home » BGI Genomics’ COVID-19 Test Gets Canadian Authorization
BGI Genomics’ COVID-19 Test Gets Canadian Authorization
BGI Genomics received authorization from Health Canada to distribute its real-time fluorescent COVID-19 polymerase chain reaction test in Canada.
The diagnostic tests respiratory samples for coronavirus RNA and produces results within three hours.
The company said it can manufacture 2 million tests per day and is handling orders from more than 80 countries.
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May